S p i n a l m u s c u l a r a t r o p h y ( S M A ) i s a g e n e t i c neuromuscular disorder characterized by progressive degeneration of the anterior horn cell leading to a lower motor neuron lesion. It is characterized by degeneration of alpha neurons in the anterior horn cells of the spinal cord leading to progressive muscle atrophy and premature death, usually from respiratory failure. 1 There are four types according to the symptoms (Table 1) .
Pregnancy can lead to deterioration in her general condition, particularly diminished respiratory function. Cesarean section is rarely encountered in patients with SMA. Muscle relaxants are contraindicated in SMA patients due to respiratory weakness. Here, we reported the successful use of total intravenous anesthesia plus muscle relaxant in a Chinese parturient with this disorder. We obtained informed consent from the patient.
A 31-year-old female presented at 35 weeks of gestation. She had been diagnosed in early childhood to be suffering from SMA. She had been wheelchair-bound for the past 15 years. At presentation, she could lift her arms up with difficulty but had no problems swallowing. She had a family history of SMA, with her brother having the same diagnosis.
Physical examination revealed that there was a short distance, near 5.5 cm, between her chin and her thyroid cartilage, with a Mallampati score of class 3. Her lower extremity muscular strength was 0-2 degrees (with 0 degree in her proximal limb and 2 degrees in her distal limb) and her upper extremity muscular strength was 2-4 degrees (with 2 degrees in her proximal limb and 4 degrees in her distal limb). She had decreased tendon reflexes in her extremities, but no pyramidal tract signs or paresthesias. Severe thoracolumbar scoliosis was also noted. Her ECG demonstrated sinus tachycardia with a heart tate of 112 beats/min. Laboratory examination revealed that her serum creatinine, creatine kinase, ALT, AST, hemoglobin, red blood cell count, and coagulation function were normal. Artery blood gas analysis showed pH 7.47, PCO 2 30 mmHg, and PO 2 78 mmHg. Severe restrictive ventilatory defect and moderate impairment of diffusing capacity were demonstrated by pulmonary function testing. We also used ulnar nerve stimulation to monitor neuromuscular function before anesthesia with train-of-four (TOF) of 2.
As her pregnancy progressed, her clinical condition progressively deteriorated with the occurrence of dyspnea. Elective cesarean section at 37 weeks was planned.
Premedication included oral ranitidine 300 mg at two intervals. The first dose of ranitidine was administered 12 hours before anesthesia and the second dose of ranitidine was administered 30 minutes before anesthesia. Bispcctral mdex (BIS) sensor was attached to her forehead before anesthesia with values above 90. Light wand, laryngeal mask, video laryngoscope, and fiberoptic bronchoscope were available before anesthesia. A 18-gauge i.v. cannula was inserted and crystalloid infusion was given. Preoxygenation for 3 minutes was followed by i.v. ketamine 20 mg, propofol 60 mg, remifentanil 50 ug, and cisatracurium besilate (Nimbex TM ) 3 mg. After 120 seconds during which time SaO 2 did not fall. Ulnar nerve stimulation showed TOF=0 and stimulated facial nerve showed TOF=2. Laryngoscopy was attempted but failed due to her challenging anatomy, which was Grade IV. The obstetricians began the incision as a laryngeal mask was positioned. A central venous catheter was quickly inserted into right internal jugular vein guided by ultrasound. Propofol and remifentanil were administered via continuous infusion, with a target BIS of 50-60. Five minutes after anesthesia induction, a live healthy male infant was delivered without complications. The 1-minute Apgar score was 8 and 5-minute Apgar score was 10. The duration of surgery, from initial incision to completion of suturing, was 38 minutes.
Neuromuscular blockade was not reversed. Nearly 40 minutes elapsed from the administration of cisatracurium until nerve stimulation (TOF) at facial nerve revealed four twitches and at ulnar nerve revealed two twitches. Spontaneous respiration quickly returned without dyspnea after anesthesia was discontinued. Then, the laryngeal mask was removed. Patient-controlled intravenous analgesia (PCIA) was administered at the conclusion of the cesarean section. Sufentanil 200 μg and metoclopramide 100 mg were infused in a 100 ml solution. The PCIA was programmed at a basal infusion of 0.1 ml/h, bolus dose of 0.5 ml with a lockout time of 7 minutes. The PCIA was continued for 2 days and the infant was doing well. She demonstrated a weak cough but was able to talk easily. Her respiration was deemed adequate and then she was transferred to ICU for observation. Seventy-two hours later, she arrived at the postnatal ward and was discharged home 1 week later after an uneventful recovery. The Brice method was applied to evaluate intraoperative awareness at 1 day and 1 week after surgery, and the results demonstrated that she did not suffer from intraoperative awareness. Her degree of neurological impairment was evaluated by the same neurologist who saw her preoperatively and she demonstrated no worsening of her SMA disease in the immediate postoperative period or at her 8-week postpartum visit.
There are a few instances in the anesthetic literature concerning SMA and general anesthesia in a parturient. Pregnancy in patients with SMA can be complicated by premature labor, exacerbation of muscle weakness, recurrent urinary tract infections, and respiratory complications. Although regional anesthesia for cesarean section has been most commonly used in patients with SMA without reported untoward effects, 2 we decided to use a general anesthetic. Our decision was based on the following rationale. First, the patient had kyphoscoliosis, which increased the difficulty of using regional anesthesia. Epidural anesthesia could be compromised due to inadequate spread of local anesthetics. Additionally, her dose requirement for spinal anesthesia was difficult to predict, and she had increased risk of either a failed or high block. Second, the use of central neuraxial blockade in patients with neurodegenerative disease and preexisting neurological disorders may increase the risk of worsening of her neurological symptoms. Third, propofol and remifentanil were chosen for their rapid elimination and help in reducing recovery time. Fourth, BIS monitoring of depth of anesthesia, while there is some controversy in its use, may help reduce the dose of general anesthetic administered allowing faster emergence and recovery. Fifth, respiratory dysfunction is a common complication of SMA; therefore, controlled ventilation under general anesthesia was necessary to ensure effective gas exchange.
Muscle relaxants can be problematic in patients with SMA.
Most published studies contended that muscle relaxants should be avoided in patients with SMA. 3, 4 We chose to administer cisatracurium 3 mg for the following reasons. First, preoperative ulnar nerve stimulation showed that TOF was 2 and facial nerve stimulation showed that it did not get affected before anesthesia. Therefore, we estimated that her requirement for cisatracurium was one-quarter of that for normal subjects. Second, cisatracurium metabolism is rapid and independent of hepatic or renal function. Yet, it must be noted that differences in the pharmacokinetics of cisatracurium besilate have been noted in various patient populations. 5 Third, some degree of muscle relaxation was necessary to reduce the possibility of laryngospasm and chest wall rigidity. Certainly monitoring the peripheral nerve stimulation guided the dose administered.
There is no doubt that pregnancy and SMA alter GI function and this patient had increased risk of aspiration associated with general anesthesia. Tracheal intubation was deemed the best way to avoid aspiration, but unfortunately, it was not successful. However, effective ventilation was achieved with the use of a laryngeal mask. Additionally, ranitidine was given to increase gastric pH and to moderate the risk of acid aspiration pneumonitis.
Low-dose ketamine is often used to produce analgesia for cesarean section as it results in minimal, if any, respiratory depression in newborns. Low dose of ketamine in conjunction with propofol sedation resulted in hypnosis without change in BIS values. Follow-up evaluation of awareness in the postoperative awareness questionnaires did not reveal that her depth of anesthesia was inadequate.
In conclusion, this is an unusual case of a Chinese parturient with SMA undergoing a cesarean section under general intravenous anesthesia and low-dose cisatracurium without complications to the patient or to her newborn.
